Online teilnehmen unter: www.springermedizin.de/cme Für diese Fortbildungseinheit werden 3 Punkte vergeben.

No abstract

To the Editor, Allergic diseases, including atopic dermatitis (AD), food allergy (FA), asthma and allergic rhinitis/rhinoconjunctivitis (AR), are the most prevalent chronic childhood diseases affecting one in four children in the Western world. 1 This global health problem imposes a significant burden on patient's quality of life, 2 family, health care and society. The current state of knowledge assumes that complex interactions between genetic and environmental factors influence a child's immune maturation prior to the development of allergic diseases. 3 To date, no reliable predictions of allergy development exist.Current scores, including clinical features and laboratory data, have only reached limited specificity and/or sensitivity. 4 In 2017, the German Federal Ministry for Education and Research funded a framework program for health research in children and adolescents: 'Healthy for life', with CHAMP (CHildhood Allergy and tolerance: bioMarkers and Predictors) being one of its projects. CHAMP is a novel multicentre German allergy consortium, which investigates the critical needs of children with allergic diseases, namely prediction of allergic diseases and improvement of health-related quality of life (HrQoL).The CHAMP consortium includes eight subprojects (SP1-8,

No abstract

No abstract